- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Potentially Undervalued Companies
Global Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
1968
Companies with a Value score of at least 3, ordered by Value score
1968 companies
Otsuka Holdings
Market Cap: US$4.8t
Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.
OTSK.Y
US$29.53
7D
4.2%
1Y
0.3%
Pharming Group
Market Cap: US$966.1m
A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.
PHAR
US$16.75
7D
-4.3%
1Y
117.0%
Puma Biotechnology
Market Cap: US$266.6m
A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.
PBYI
US$5.30
7D
5.0%
1Y
69.9%
NovaBridge Biosciences
Market Cap: €459.9m
A biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States.
0VY
€3.36
7D
3.1%
1Y
246.4%
Hypera
Market Cap: US$17.5b
Operates as a pharmaceutical company in Brazil.
HYPM.Y
US$4.69
7D
-4.6%
1Y
52.7%
Merck
Market Cap: €250.4b
Operates as a healthcare company worldwide.
6MK
€85.50
7D
-5.4%
1Y
-11.9%
CSPC Pharmaceutical Group
Market Cap: €88.1b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
CVG
€0.83
7D
-4.0%
1Y
41.1%
Iovance Biotherapeutics
Market Cap: €873.3m
A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States.
1IOVA
€1.86
7D
12.1%
1Y
n/a
MariMed
Market Cap: CA$31.6m
Engages in cultivation, production, and selling of branded cannabis products in the United States and internationally.
MRMD
CA$0.10
7D
-20.0%
1Y
-48.7%
Novo Nordisk
Market Cap: DKK 1.4t
Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.
0QIU
DKK 309.27
7D
-1.1%
1Y
-60.6%
Bayer
Market Cap: US$32.8b
Operates as a life science company worldwide.
BAYR.Y
US$9.67
7D
9.8%
1Y
83.7%
H. Lundbeck
Market Cap: €42.4b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
LDBB
€4.63
7D
-2.1%
1Y
-3.6%
Veru
Market Cap: US$38.8m
A late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS).
VERU
US$2.49
7D
0.4%
1Y
-65.1%
Bausch Health Companies
Market Cap: US$2.7b
Operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally.
BHC
US$6.93
7D
9.1%
1Y
-15.0%
SCHOTT Pharma KGaA
Market Cap: €2.6b
Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide.
1SXP
€16.98
7D
-10.3%
1Y
-35.7%
United Therapeutics
Market Cap: US$20.8b
A biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.
UTHR
US$489.31
7D
0.7%
1Y
32.4%
Marinomed Biotech
Market Cap: €36.2m
A biopharmaceutical company, develops therapeutic products for indications in virology and immunology in Austria, other European countries, and internationally.
93Z
€18.35
7D
0%
1Y
32.0%
GSK
Market Cap: R$72.4b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
G1SK34
R$52.75
7D
3.1%
1Y
25.4%
Biogen
Market Cap: R$26.7b
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.
BIIB34
R$165.44
7D
1.9%
1Y
3.8%
Delivra Health Brands
Market Cap: €7.5m
Through its subsidiaries, engages in the health and wellness consumer packaged goods business worldwide.
3F0
€0.13
7D
-8.2%
1Y
106.2%
GSK
Market Cap: UK£72.4b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSKL
UK£18.03
7D
0.8%
1Y
34.0%
Merck KGaA
Market Cap: US$52.5b
Operates as a science and technology company in Germany and internationally.
MKKG.Y
US$27.98
7D
3.7%
1Y
-4.7%
Telix Pharmaceuticals
Market Cap: US$5.0b
A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.
TLX
US$9.85
7D
-1.0%
1Y
-41.0%
Biogen
Market Cap: €26.7b
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.
IDP
€155.20
7D
-0.06%
1Y
3.5%
Bavarian Nordic
Market Cap: €14.9b
Develops, manufactures, and supplies life-saving vaccines.
BV3A
€8.35
7D
-18.1%
1Y
-0.6%
Genmab
Market Cap: €125.2b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GE91
€27.40
7D
1.5%
1Y
33.0%
TerrAscend
Market Cap: US$302.6m
TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.
TSND.F
US$0.54
7D
19.0%
1Y
-29.4%
Faes Farma
Market Cap: €1.5b
Researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally.
FFEA
€4.76
7D
1.3%
1Y
37.4%
Shionogi
Market Cap: US$2.3t
Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.
SGIO.Y
US$8.51
7D
-0.9%
1Y
15.6%
Anika Therapeutics
Market Cap: US$136.9m
A joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally.
ANIK
US$9.60
7D
-2.8%
1Y
-45.0%
Regeneron Pharmaceuticals
Market Cap: US$74.2b
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.
REGN
US$718.36
7D
-7.9%
1Y
-7.7%
CorMedix
Market Cap: US$838.3m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$10.56
7D
7.6%
1Y
11.2%
Genmab
Market Cap: €125.2b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GE9
€270.80
7D
-0.6%
1Y
30.6%
Johnson & Johnson
Market Cap: US$487.8b
Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.
JNJ
US$201.93
7D
-2.4%
1Y
35.2%
Merck
Market Cap: US$250.4b
Operates as a healthcare company worldwide.
MRK
US$99.72
7D
-4.9%
1Y
-3.3%
Pfizer
Market Cap: US$148.0b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
0Q1N
US$26.03
7D
1.1%
1Y
0.9%